Cytotoxicity of butylated hydroxyanisole in Vero cells

Cell Biology and Toxicology

Volumn 23, Issue 3, 2007, Pages 189-199

  Labrador, V ^a   Fernandez Freire P ^a   Perez Martin J M ^a   Hazen, M J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Butylated hydroxyanisole; Cytotoxicity; Growth inhibition; Microscopy; Vero cells

Indexed keywords

BUTYLATED HYDROXYANISOLE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; COSMETIC INDUSTRY; CYTOTOXICITY; FOOD INDUSTRY; MAMMAL CELL; MICROSCOPY; MITOCHONDRIAL TOXICITY; MITOCHONDRION SWELLING; NONHUMAN; PRIORITY JOURNAL; VERO CELL;

ACTINS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BUTYLATED HYDROXYANISOLE; CELL PROLIFERATION; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CYTOSKELETON; LYSOSOMES; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; VERO CELLS;

MAMMALIA;

EID: 34250155338     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-006-0153-6     Document Type: Article

References (49)

1. Ashworth SL, Southgate EL, Sandoval RM, Meberg PJ, Bamburg JR, Molitoris BA. ADF/cofilin mediates actin cytoskeletal alterations in LLC-PK cells during ATP depletion. Am J Physiol Renal Physiol. 2003;284:F852-862.
2. Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys. 1993;303:474-482.
3. Botterweck A, Verhagen H, Goldbohm R, Kleinjans J, Brandt P. Intake of butylated hydroxyanisole and butylated hydroxytoluene and stomach cancer risk: results from analyses in The Netherlands cohort study. Food Chem Toxicol. 2000;38:599- 605.
4. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
5. Clayson D, Iverson F, Nera E, Lok E. The significance of induced forestomach tumors. Annu Rev Pharmacol Toxicol. 1990;30:441-463.
6. Clemedson C, Barile F, Chesné C, Cottin M, Curren R, Ekwall B, Ferro M, Gómez - Lechón M, Imai K, Janus J, Kemp R, Kerszman G, Kjellstrand P, Lavrijsen K, Logenmann P, McFarlane-Abdulla E, Roguet R, Segner H, Seibert H, Thuvander A, Walum E, Ekwall B. MEIC evaluation of acute systemic toxicity:Part VII. Prediction of human toxicity by results from testing of the first 30 reference chemicals with 27 further in vitro assays. Altern Lab Anim. 2000;28:161-200.
7. Commission Directive 2001/59/EC of 6 August 2001 adapting to technical progress for the 28th time Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances.
8. Demaurex N. pH homeostasis of cellular organelles. News Physiol Sci. 2002;17:1-5.
9. Eisenbrand G, Pool-Zobel B, Baker V, Balls M, Blaauboer B, Boobis A, Carere A, Kevekordes S, Lhuguenot J, Pieters R, Kleiner J. Methods of in vitro toxicology. Food Chem Toxicol. 2002;40:193-236.
10. Ekwall B, Silano V, Paganuzzi-Stammati A, Zucco F. Toxicity test with mammalian cell cultures. In: Bourdeau P, ed. Short-term toxicity test for non-genotoxic effects. New York: John Wiley & Sons Ltd;1990:75-97.
11. Fernández Freire P, Labrador V, Pérez Martín J, Hazen M. Cytotoxic effects in mammalian Vero cells exposed to pentachlorophenol. Toxicology. 2005;210:37-44.
12. Fukumoto L, Mazza G. Assessing antioxidant and prooxidant activities of phenolic compounds. J Agric Food Chem. 2000;48:3597-3604.
13. Gennari A, van den Berghe C, Casati S, Castell J, Clemedson C, Coecke S, Colombo A, Curren R, Dal Negro G, Goldberg A, Gosmore C, Hartung T, Langezaal I, Lessigiarska I, Ryan M, Schmuck G, Stitzel K, Stokes W, Vericat J, Gribaldo L. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM workshop 50. Alternatives to Laboratory Animals. 2004;32:437-459.
14. Gilkerson R, Margineantu D, Capaldi R, Selker J. Mitochondrial DNA depletion causes morphological changes in the mitochondrial reticulum of cultured human cells. FEBS Lett. 2000;474:1-4.
15. Henics T, Wheatley D. Cytoplasmic vacuolation, adaptation and cell death: a view on new perspectives and features. Biology of the Cell. 1999;91:485-498.
16. Herget-Rosenthal S, Hosford M, Kribben A, Atkinson S, Sandoval R, Molitoris B. Characteristics of EYFP-actin and visualization of actin dynamics during ATP depletion and repletion. Am J Physiol Cell Physiol. 2001;281:1858-1870.
17. Ito N, Fukushima S, Hagiwara A, Shibata M, Omiso T. Carcinogenicity of butylated hydroxyanisole in F344 rats. J Natl Cancer Inst. 1983;70:343-352.
18. Iverson F, Truelove J, Nera E, Wong J, Lok E, Clayson D. An 85-day study of butylated hydroxyanisole in the cynomolgus monkey. Cancer Lett. 1985;26:43-50.
19. Jakab M, Fürst J, Gschwentner M, Bottà G, Garavaglia M, Bazzini C, Rodighiero S, Meyer G, Eichmüller S, Wöll E, Chwatal S, Ritter M, Paulmichl M. Mechanisms sensing and modulating signals arising from cell swelling. Cell Physiol Biochem. 2002;12: 235-258.
20. Jos A, Repetto G, Ríos J, del Peso A, Salguero M, Hazen M, Molero M, Fernández Freire P, Pérez Martín J, Labrador V, Cameán A. Ecotoxicological evaluation of the additive butylated hydroxyanisole using a battery with six model systems and eighteen endpoints. Aquat Toxicol. 2005;71:183-192.
21. Kirlin W, Cai J, DeLong M, Patten E, Jones D. Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J Nutr. 1999;129:1827-1835.
22. Kong A, Yu R, Hebbar V, Chen C, Owuor E, Hu R, Ee R, Mandlekar S. Signal transduction events elicited by cancer prevention compounds. Mutat Res. 2001;480-481:231-241.
23. Lang F, Busch G, Ritter M, Völkl H, Waldegger S, Gulbins E, Häussinger D. Functional significance of cell volume regulatory mechanisms. Physiol Rev. 1998;78:247-306.
24. Law P, Campbell S, Lepock J, Kruuv J. Effects of butylated hydroxytoluene on membrane lipid fluidity and freeze-thaw survival in mammalian cells. Cryobiology. 1986;23:317-322.
25. Leclercq C, Arcella D, Turrini A. Estimates of the theoretical maximum daily intake of erythorbic acid, gallates, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) in Italy: a stepwise approach. Food Chem Toxicol. 2000;38:1075-1084.
26. Lyamzaev K, Pletjushkina O, Saprunova V, Bakkeva L, Chernyak B, Skulachev V. Selective elimination of mitochondria from living cells induced by inhibitors of bioenergetic functions. Biochem Soc Trans. 2004;32:1070-1071.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
28. Murphy MP. Slip and leak in mitochondrial oxidative phosphorylation. Biochim Biophys Acta. 1989;977:123-141.
29. Nera E, Iverson F, Lok E, Armstrong C, Karpinski K, Clayson D. A carcinogenesis reversibility study of the effects of butylated hydroxyanisole on the forestomach and urinary bladder in male Fischer 344 rats. Toxicology. 1988;53:251-268.
30. Okada Y, Maeno E, Shimizu T, Dezaki K, Wang J, Morishima S. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol. 2001;532:3-16.
31. Okubo T, Yokoyama Y, Kano K, Kano I. Molecular mechanism of cell death induced by the antioxidant tert-butylhydroxyanisole in human monocytic leukemia U937 cells. Biol Pharm Bull. 2004;27:295-302.
32. Peters M, Rivera M, Jones T, Monks T, Lau S. Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder. Cancer Res. 1996;56:1006-1011.
33. Picardo M, Passi S, Nazzaro-Porro M, Breathnach A, Zompetta C, Faggioni A, Riley P. Mechanism of antitumoral activity of catechols in culture. Biochem Pharmacol. 1987;36:417-425.
34. Revenu C, Athman R, Robine S, Louvard D. The co-workers of actin filaments: from cell structures to signals. Nat Rev Mol Cell Biol. 2004;5:635-646.
35. Sarafian T, Kouyoumjian S, Tashkin D, Roth M. Synergistic cytotoxicity of Delta(9)-tetrahydrocannabinol and butylated hydroxyanisole. Toxicol Lett. 2002;133:171-179.
36. Satoh K, Atsumi T, Sakagami H, Kashiwagi Y, Ida Y, Ueha T, Sugita Y, Yokoe I, Fujisawa S. Radical intensity and cytotoxicity of butylated hydroxyanisole and its orthobisphenol dimer. Anticancer Res. 1999;17:3947-3952.
37. Sgaragli G, Corte L, Rizzotti-Conti M, Giotti A. Effects of monocyclic compounds on biomembranes. Biochem Pharmacol. 1977;26:2145-2149.
38. 2+)- ATPase of sarcoplasmic reticulum. FEBS Lett. 1986;203:121-126.
39. Spielmann H, Genschow E, Liebsch M, Halle W. Determination of the starting dose for acute oral toxicity (LD50) testing of up and down procedure (UDP) from cytotoxicity data. Alternatives to Laboratory Animals. 1999;27:957-966.
40. Thompson D, Moldéus P. Cytotoxicity of butylated hydroxyanisole and butylated hydroxytoluene in isolated rat hepatocytes. Biochem Pharmacol. 1988;37:2201-2207.
41. Williams G, Tanaka T, Maeura Y. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis. 1986;7: 1043-1050.
42. Williams G, McQueen C, Tong C. Toxicity studies of butylated hydroxyanisole and butylated hydroxytoluene. Genetic and cellular effects. Food Chem Toxicol. 1990;28:793-798.
43. Williams GM, Iatropoulos MJ. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Cancer Lett. 1996;104:49-53.
44. Williams G, Iatropoulos M. Anticarcinogenic effects of synthetic phenolic antioxidants. In: Baskin S, Salem H, eds. Oxidants, Antioxidants and free radicals. New York: Taylor & Francis;1997:341-350.
45. Williams GM, Iatropoulos MJ, Whysner J. Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives. Food Chem Toxicol. 1999;37:1027- 1038.
46. Wurtzen G, Olsen P. BHA study in pigs. Food Chem Toxicol. 1986;24:1229-1233.
47. Yu R, Mandlekar S, Kong A. Molecular mechanisms of butylated hydroxylanisole-induced toxicity: induction of apoptosis through direct release of cytochrome c. Mol Pharmacol. 2000;58:431-437.
48. Zhang G, Liu H, Yang L, Zhong Y, Zheng Y. Influence of membrane physical state on the lysosomal proton permeability. J Membr Biol. 2000;175:53-62.
49. Zucco F, De Angelis I, Testai E, Stammati A. Toxicology investigation with cell culture system: 20 years after. Toxicol in Vitro. 2004;18:153-163.